UVLrx Therapeutics Release: Minnesota-Based Doctor Studies Impact Of UV Light On Flu Virus

Drs. Bradley Bush and Rebecca Bush Assess Effectiveness of Light Therapy in Treating Influenza

MINNEAPOLIS--(BUSINESS WIRE)--According to the CDC, 200,000 people are hospitalized each year for the flu and nearly 20% of the U.S. population suffers from the virus over the course of flu season. Doctor Bradley Bush at Stillwater Natural Medicine of Stillwater is looking toward the light to fight this bug. This week, Bush is joining a select group of doctors throughout the United States in an influenza study to assess the ability of an investigational light-based medical device by UVLrx Therapeutics™ to reduce the severity and duration of influenza symptoms, both systemic and upper respiratory.

“We’re hoping that the use of specific wavelengths of light will prove effective in getting people over the flu and back to their daily lives quickly”

The treatment device uses specific wavelengths of light to target the influenza virus while supporting the body’s immune system to help combat or fight the viral infection. The study aims at assessing the effectiveness and safety of this application.

Influenza commonly causes both systemic and upper respiratory symptoms, which include nasal congestion, cough, body aches, malaise and fever. These symptoms can last between 7 to 14 days and can greatly alter a person’s quality of life and ability to work.

“We’re hoping that the use of specific wavelengths of light will prove effective in getting people over the flu and back to their daily lives quickly,” said Dr. Bush.

Study participants will undergo four sixty-minute treatments in one week in a medical clinic at no cost to the patient. Additionally, participants will return to the clinic for two more evaluations to assess symptom resolution.

To participate in the study, please call (651) 342-1043 or visit the Natural Medicine of Stillwater at 105 New England Place, Suite 220, Stillwater, MN 55082.

About UVLrx Therapeutics
Based in Oldsmar, Florida, UVLrx Therapeutics is dedicated to evidence-based medicine in the field of light therapy and offers the first intravenous, concurrent delivery of ultraviolet-A (UVA) and multiple visible light wavelengths for treating a variety of medical issues. In addition to two Nobel Prizes and NASA-backed research, hundreds of international clinical trials have verified the health benefits of UV and other wavelengths of light utilized in the UVLrx™ Treatment System. For more information, please visit www.uvlrx.com.